Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/PRLD/Shareholders’ equity

PRELUDE THERAPEUTICS INC (PRLD) Shareholders’ equity 2024–2025

PRELUDE THERAPEUTICS INC (PRLD) shareholders’ equity at each fiscal year-end, per SEC filings.

$68.6MFY2025 · since FY2024: $131.5M → $68.6M
2425
Fiscal yearValueYoY
FY2025$68.6M-47.8%
FY2024$131.5M—

Source: SEC XBRL filings · For reference only · Not investment advice

More PRLD financial trends

PRLD RevenuePRLD Net incomePRLD Net marginPRLD Gross profitPRLD Gross marginPRLD Operating incomePRLD Operating marginPRLD Operating cash flowPRLD Free cash flowPRLD Capital expendituresPRLD Return on equityPRLD Stock buybacksPRLD Dividends paidPRLD Total assetsPRLD Total liabilitiesPRLD overview →